Kay Thrilled by Memogain’s Prospects
Denis Kay has been a scientist for a long time, but he’s most thrilled by his current role working on a promising drug for Alzheimer’s disease.
Alzheimer’s is an escalating problem in aging societies. It’s estimated that the worldwide annual market for Alzheimer’s drugs is already $3.8 billion, although the cost to society is far greater.
“Sometimes I can’t sleep at night because of my excitement over the drug and working for a small biotech venture,” said Kay, who is a founder and chief scientific officer of Charlottetown’s Neurodyn Life Sciences.
Kay is energized because Neurodyn’s